$VICR

Lavie Zmira sold $273K of VICR

Lavie Zmira sold 1,216 shares of VICOR CORP (VICR) at $224.72 ($0.27M total) on 2026-07-23.

Original reporting
SEC EDGAR · Lavie Zmira
Published Jul 27, 2026, 3:09 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 27, 2026, 3:11 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The filing discloses an open-market sale of 1,216 shares at $224.72/share, leaving the director with 0 shares, but provides no accompanying rationale or company performance update.

02

Market read

Traders may monitor for insider activity trends, but this single Form 4 sale is unlikely to drive a fundamental repricing without additional corroborating news.

03

What to watch

Check for clustering of insider transactions across multiple directors/officers and whether subsequent Form 4s show purchases or additional sales around the same period.

Relevance 4/10Novelty 3/10Timing: Filed 2026-07-27, disclosing a sale dated 2026-07-23.

Background

The article is a primary-source SEC Form 4 insider transaction for VICOR Corp, reported by director Lavie Zmira.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

Lavie Zmira, a VICOR Corp director, sold 1,216 shares in an open-market transaction for about $273.3K at $224.72/share.

Expected impact

Likely limited near-term impact; any effect would be sentiment-only unless follow-on filings show unusual patterns.

Evidence & confidence

Form 4 insider sales are common and this filing provides only transaction details, not earnings, guidance, or operational changes. The absence of a pre-arranged 10b5-1 plan can raise scrutiny, but the disclosed size and director role alone are insufficient to imply a fundamental shift.

Market effects

No direct sector read-through; this is company-specific insider transaction data only.

None indicated.

None indicated.

Counterpoint

The sale could be for personal liquidity needs and does not necessarily reflect negative expectations, especially given the small absolute share count.

Key entities

  • VICOR CORP

    Company whose director insider sale is disclosed on Form 4.

  • Lavie Zmira

    Director who sold 1,216 shares in an open-market transaction.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$MXLHighAI 8/10

MXL vs. VICR: Which Has the Better AI Infrastructure Opportunity?

MaxLinear (MXL) and Vicor (VICR) are positioned to benefit from AI infrastructure growth. MXL reported 55% revenue growth in Q2 2026, driven by optical and electrical interconnects. Vicor focuses on power delivery for AI processors. MXL's AI products, like Keystone and Rushmore, are in high demand, with new products expected to launch in 2027 and 2028.

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: